GALVmed is implementing AgResults’ US $30 million Brucellosis Vaccine Prize competition, aimed at incentivising the development of a suitable vaccine that is efficacious, safe and viable for use against Brucella […]

At GALVmed, we work with partners to makes livestock vaccines, medicines and diagnostics accessible and affordable to smallholder farmers in Africa and South Asia. But why livestock vaccines and health […]

Today, 8th March, the world celebrates International Women’s Day, which is an important catalyst and vehicle for driving greater change for women while moving closer to gender equality. This year’s […]

Porcine cysticercosis is a zoonotic disease, which can lead to epilepsy in humans. A new vaccine and dewormer have been registered to counter the disease in pigs thereby stopping the […]

East Coast Fever (ECF) is a serious, often fatal, disease of cattle that causes major economic losses across 11 countries in eastern, central and southern Africa. Caused by single-celled parasite, […]

For farmers to benefit from animal health products, there has to be a reliable and sustainable supply chain to deliver the products. GALVmed is working with Hester Biosciences Ltd. in […]

What’s your reaction to the US $30m Brucellosis prize competition and that it’s funded by the private sector? Gwyn Jones, Chairman of the Responsible Use of Medicines in Agriculture Alliance […]

What’s your reaction to the US $30m Brucellosis prize competition and that it’s funded by the private sector? Peter Oostenbach, Associate Director for Global Public Policy Animal Health at Merck […]

Why is a vaccine against B. melitensis important? George Tice, Senior Director of Market Access for Europe, Middle East and Africa at Elanco Animal Health responds with his personal view. […]

If the Brucellosis Vaccine Prize Competition results in a vaccine, do you think companies could start looking at diseases that remain untreated? Brigitte Boenisch, Head of Regulatory Affairs for Europe, […]